NFKB1 and prostate carcinoma: Similar observations have been made in prostate cancer cells [33], thereby providing substantial evidence for a mechanism by which decreased NF-κB signaling in the 8505C cell line leads to decreased cyclin B1 expression in a p21-dependent manner.